These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 354471)

  • 1. Double-blind study of carbenoxolone in gastric ulcer and erosions.
    Lehtola J; Karvonen AL; Tunturi-Hihnala H
    Ann Clin Res; 1978 Feb; 10(1):19-23. PubMed ID: 354471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double blind trial of carbenoxolone and geranyl farnesyl acetate in gastric ulcer.
    Smith PM; Sladen GE; Beck ER; Bennett PN; Lennard JE; Langman JS
    Scand J Gastroenterol; 1975; 10(7):753-5. PubMed ID: 1103273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbenoxolone patients with gastric ulcers. A double-blind trial.
    Schwamberger K; Reissigl H
    Scand J Gastroenterol Suppl; 1980; 65():59-62. PubMed ID: 7010529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of pirenzepine and carbenoxolone in the treatment of chronic gastric ulcer. A double-blind endoscopic trial.
    Bianchi Porro G; Petrillo M; Lazzaroni M; Mazzacca G; Sabbatini F; Piai G; Dobrilla G; De Pretis G; Daniotti S
    Hepatogastroenterology; 1985 Dec; 32(6):293-5. PubMed ID: 3912314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of carbenoxolone sodium in the treatment of duodenal ulcer.
    Nagy GS
    Gastroenterology; 1978 Jan; 74(1):7-10. PubMed ID: 336453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of amiloride on the therapeutic and metabolic effects of carbenoxolone in patients with gastric ulcer. A double-blind controlled trial.
    Reed PI; Lewis SI; Vincent-Brown A; Holdstock DJ; Gribble RJ; Murgatroyd RE; Baron JH
    Scand J Gastroenterol Suppl; 1980; 65():51-7. PubMed ID: 7010528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effective out-patient treatment of gastric ulcer with proglumide: preliminary results (author's transl)].
    Miederer SE; Lindstaedt H; Kutz K; Wuttke H
    Dtsch Med Wochenschr; 1979 Mar; 104(9):313-5. PubMed ID: 761539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer.
    Maconi G; Lazzaroni M; Sangaletti O; Bargiggia S; Vago L; Bianchi Porro G
    Am J Gastroenterol; 1997 Oct; 92(10):1844-8. PubMed ID: 9382049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness of carbenoxolone in the treatment of gastro-duodenal ulcer patients.
    Loginov AS; Speransky MD; Speranskaya IE; Vasilyev UV; Alecseev VF
    Scand J Gastroenterol Suppl; 1980; 65():85-91. PubMed ID: 7010530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of peptic ulcer with Biogastrone (carbenoxolone)].
    Brailski Kh; Dimitrov B
    Vutr Boles; 1979; 18(5):37-44. PubMed ID: 516651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healing of NSAID-induced gastric ulcers with a synthetic prostaglandin analog (enprostil).
    Sontag SJ; Schnell TG; Budiman-Mak E; Adelman K; Fleischmann R; Cohen S; Roth SH; Ipe D; Schwartz KE
    Am J Gastroenterol; 1994 Jul; 89(7):1014-20. PubMed ID: 8017358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pirenzepine (LS 519) in severe duodenal ulcer and in gastric ulcer. A double-blind clinical trial.
    Oselladore D; Chierichetti SM; Norberto L; Vibelli C
    Scand J Gastroenterol Suppl; 1979; 57():33-9. PubMed ID: 396655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoprotective therapy of gastric ulcers: a controlled clinical evaluation of triletide versus carbenoxolone.
    Campisi D; Cataldo MG; Paterna S; Bivona A; Barbarino C
    Pharmatherapeutica; 1985; 4(3 Spec No):166-70. PubMed ID: 3903785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of 3-hydroxy-lup-20(29)en-23-28-dioic acid on rat experimental gastric ulcers].
    Zhang SR
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Jun; 12(3):198-202. PubMed ID: 2150356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of 'cytoprotective' drugs (carbenoxolone, zolimidine, prostanoic acid) on mucus secretion in patients with gastric ulcer.
    Parodi MC; Molinari F; Barocci S
    Scand J Gastroenterol Suppl; 1984; 92():163-6. PubMed ID: 6234649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symposium on peptic ulcer disease. 1. Medical treatment of peptic ulcer.
    Jeejeebhoy KN
    Can J Surg; 1978 Jan; 21(1):17-8. PubMed ID: 579607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbenoxolone: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease.
    Pinder RM; Brogden RN; Sawyer PR; Speight TM; Spencer R; Avery GS
    Drugs; 1976; 11(4):245-307. PubMed ID: 780088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comments on the effects of carbenozolone and trimipramine on peptic ulcer healing.
    Myren J; Berstad A
    Scand J Gastroenterol Suppl; 1976; 42():159-61. PubMed ID: 796969
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of Duogastrome (carbenoxolone sodium) for the treatment of duodenal ulcer: a multicentre study.
    Archambault A; Farley A; Gosselin D; Martin F; Birkett JP
    Can Med Assoc J; 1977 Nov; 117(10):1155-9. PubMed ID: 603844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic efficacy of misoprostol in peptic ulcer disease.
    Watkinson G; Hopkins A; Akbar FA
    Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.